| |
|
|
| Name: |
Soleus Capital Management L.P. |
| City: |
GREENWICH |
| State: |
CT |
| Zip: |
06830 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
24 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
BGNE |
Beigene Ltd |
16 |
New |
$154.25 |
$23,161,000 |
148,100 |
2.03% |
23,161,000 |
148,100 |
0.163 |
N/A |
|
|
BIIB |
Biogen Idec Inc |
26 |
New |
$220.07 |
$15,698,000 |
72,800 |
1.38% |
15,698,000 |
72,800 |
0.047 |
Biotechnology |
|
|
ENGN |
Engene Holdings Inc. |
32 |
New |
$10.50 |
$13,560,000 |
800,000 |
1.19% |
13,560,000 |
800,000 |
3.448 |
N/A |
|
|
NARI |
Inari Medical, Inc. |
33 |
New |
$0.00 |
$13,290,000 |
277,000 |
1.17% |
13,290,000 |
277,000 |
0.536 |
N/A |
|
|
ENTA |
Enanta Pharmaceuticals Inc |
38 |
New |
$12.00 |
$10,136,000 |
580,546 |
0.89% |
10,136,000 |
580,546 |
2.893 |
Biotechnology |
|
|
CGON |
CG Oncology, Inc |
41 |
New |
$34.29 |
$9,565,000 |
217,871 |
0.84% |
9,565,000 |
217,871 |
0.33 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
51 |
New |
$0.00 |
$7,449,000 |
658,000 |
0.65% |
7,449,000 |
658,000 |
1.194 |
N/A |
|
|
MNKD |
MannKind Corp |
54 |
New |
$4.50 |
$7,060,000 |
1,558,537 |
0.62% |
7,060,000 |
1,558,537 |
0.67 |
Biotechnology |
|
|
MNMD |
Mind Medicine |
55 |
New |
$8.81 |
$7,052,000 |
750,237 |
0.62% |
7,052,000 |
750,237 |
2.112 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
57 |
New |
$3.45 |
$6,386,000 |
870,000 |
0.56% |
6,386,000 |
870,000 |
0.734 |
Biotechnology |
|
|
XFOR |
X4 Pharmaceuticals Inc |
58 |
New |
$0.98 |
$6,366,000 |
4,579,926 |
0.56% |
6,366,000 |
4,579,926 |
2.738 |
N/A |
|
|
JANX |
Janux Therapeutics, Inc. |
61 |
New |
$0.00 |
$5,941,000 |
157,800 |
0.52% |
5,941,000 |
157,800 |
0.395 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
62 |
New |
$0.00 |
$5,789,000 |
421,000 |
0.51% |
5,789,000 |
421,000 |
0.628 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
65 |
New |
$11.25 |
$4,578,000 |
386,000 |
0.4% |
4,578,000 |
386,000 |
1.015 |
N/A |
|
|
RGLS |
Regulus Therapeutics Inc. |
66 |
New |
$2.26 |
$4,500,000 |
1,562,500 |
0.4% |
4,500,000 |
1,562,500 |
1.07 |
Biotechnology |
|
|
CALC |
Calcimedica Ord Shs |
69 |
New |
$0.44 |
$3,261,000 |
783,904 |
0.29% |
3,261,000 |
783,904 |
13.85 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
70 |
New |
$0.00 |
$3,243,000 |
300,000 |
0.28% |
3,243,000 |
300,000 |
0.617 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
71 |
New |
$0.70 |
$3,000,000 |
100,000 |
0.26% |
3,000,000 |
100,000 |
0.675 |
N/A |
|
|
CRVO |
Cervomed Ord Shs |
72 |
New |
$0.17 |
$2,950,000 |
126,614 |
0.26% |
2,950,000 |
126,614 |
2.233 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
73 |
New |
$0.00 |
$2,655,000 |
925,000 |
0.23% |
2,655,000 |
925,000 |
0.495 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
76 |
New |
$8.66 |
$2,230,000 |
225,000 |
0.2% |
2,230,000 |
225,000 |
0.211 |
N/A |
|
|
CVRX |
Cvrx, Inc. |
83 |
New |
$6.88 |
$883,000 |
48,500 |
0.08% |
883,000 |
48,500 |
0.262 |
N/A |
|
|
FOLD |
Amicus Therapeutics Inc |
85 |
New |
$10.61 |
$683,000 |
57,966 |
0.06% |
683,000 |
57,966 |
0.017 |
Biotechnology |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
86 |
New |
$0.00 |
$639,000 |
122,222 |
0.06% |
639,000 |
122,222 |
0.191 |
N/A |
|
